Avalo Therapeutics (AVTX) Change in Inventory (2017 - 2023)
Avalo Therapeutics (AVTX) posted Change in Inventory of -$18000.0 for Q3 2023, down 1700.0% on a QoQ basis from -$1000.0 in Q2 2023, and down 1700.0% year-over-year from $1125.0 in Q3 2022.
Avalo Therapeutics (AVTX) Change in Inventory (2017 - 2023) Analysis & Trends
Avalo Therapeutics' Change in Inventory history runs 7 years deep, the most recent figure standing at -$18000.0 for Q3 2023.
- Quarterly Change in Inventory fell 1700.0% year-over-year to -$18000.0 in Q3 2023, while the trailing twelve-month figure through Jun 2024 was -$18000.0 (down 260.0% YoY) and the FY2023 annual result came in at -$20000.0, down 11.11% from the prior year.
- Change in Inventory was -$18000.0 for Q3 2023 at Avalo Therapeutics, down from -$1000.0 in the prior quarter.
- Across five years, Change in Inventory topped out at $68294.0 in Q4 2019 and bottomed at -$411736.0 in Q2 2019.
- A 5-year average of -$29155.1 and a median of -$3000.0 in 2020 frame the typical range for Change in Inventory.
- Annual changes were most pronounced in 2021 — Change in Inventory surged 600.0% — and 2023, when it plunged 1700.0%.
- Avalo Therapeutics' Change in Inventory stood at $68294.0 in 2019, then slumped by 108.79% to -$6000.0 in 2020, then jumped by 466.67% to $22000.0 in 2021, then slumped by 109.09% to -$2000.0 in 2022, then tumbled by 800.0% to -$18000.0 in 2023.
- Business Quant data shows AVTX's Change in Inventory at -$18000.0 in Q3 2023, -$1000.0 in Q2 2023, and -$1000.0 in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 71.84 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 97.70 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -26.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Avalo Therapeutics | 1.04 Mn | 1.04 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -18,000.00 |
| Sep 30, 2023 | -18,000.00 |
| Jun 30, 2023 | -1,000.00 |
| Jun 30, 2023 | -1,000.00 |
| Mar 31, 2023 | -1,000.00 |
| Mar 31, 2023 | -1,000.00 |
| Dec 31, 2022 | -2,000.00 |
| Dec 31, 2022 | -2,000.00 |
| Sep 30, 2022 | -1,000.00 |
| Sep 30, 2022 | -1,000.00 |
| Jun 30, 2022 | -2,000.00 |
| Jun 30, 2022 | -2,000.00 |
| Mar 31, 2022 | -13,000.00 |
| Mar 31, 2022 | -13,000.00 |
| Dec 31, 2021 | 22,000.00 |
| Dec 31, 2021 | 22,000.00 |
| Sep 30, 2021 | -4,000.00 |
| Sep 30, 2021 | -4,000.00 |
| Jun 30, 2021 | 20,000.00 |
| Jun 30, 2021 | 20,000.00 |